An experienced antitrust attorney, Josh Shapiro helps clients navigate through the regulatory review of mergers and acquisitions.
This includes deal inception and risk assessment to clearance by the US Federal Trade Commission and Department of Justice.
His practice spans a broad range of industries, including pharmaceuticals, medical devices, chemicals, insurance, energy, food and beverage, mining, retail, financial products, aviation, animal health, automotive, seafood, software, spirits, technology and telecommunications.
Josh also provides strategic advice and counseling to domestic and international clients on critical competition questions, and has extensive antitrust litigation experience. Additionally, he regularly provides clients with training and guidance on antitrust compliance issues.
His extensive experience includes a secondment as antitrust counsel in the London office of a global financial institution, where he provided antitrust counseling and served as in-house counsel for cross-jurisdictional internal investigations and litigation.
Active in the Antitrust Section of the American Bar Association, Josh also currently serves as Vice Chair of the US Comments and Policy Committee.
Latest Insights
Latest News
- firm newsEversheds Sutherland Advises GLGH Steel on Definitive Agreement to Sell 100% of the Share Capital of Artrom Steel Tubes S.A. to Tenaris S.A.
- client newsEversheds Sutherland Advises Cox Automotive on Definitive Agreement to Acquire Fullpath, Bringing AI-Native Data and Marketing Infrastructure to the Industry’s Largest Dealer Network
- client newsEversheds Sutherland Advises MiddleGround Capital and Lindsay Precast on Sale of Lindsay Precast to TJC
firm news
May 08, 2026
Eversheds Sutherland Advises GLGH Steel on Definitive Agreement to Sell 100...
client news
May 01, 2026
Eversheds Sutherland Advises Cox Automotive on Definitive Agreement to Acqu...
client news
December 22, 2025
Eversheds Sutherland Advises MiddleGround Capital and Lindsay Precast on Sa...
- Represented Azurity Pharmaceuticals, Inc., Azurity Ireland Limited and QHP Capital in the acquisition of Covis Pharma Group S.a r.l.
- Represented Kiwa, N.V., a leading global player in the Testing, Inspection and Certification sector, on its strategic acquisition of National Quality Assurance.
- Represented Rheem Manufacturing in its acquisition of Nortek Global HVAC.
- Represented Arch U.S. MI Holdings Inc., a wholly-owned subsidiary of Arch Capital Group Ltd., on its acquisition of RMIC Companies, Inc.
- Represented Amergin Asset Management and Amergin Rail in is acquisition of PNC Bank’s operating railcar portfolio.
- The Antitrust Revolution: The Rise of Enforcement and Its Effect on Corporate Law, April 3, 2024, The Emory Corporate Governance and Accountability Review 2024 Symposium
- Global Competition Review’s “GCR 100” – “Recommended” for US antitrust practice (2026)
- Recognized by The Legal 500 United States in the area of Merger Control (2025)
- Named to Who's Who Legal's Competition Future Leaders – Partners (2022-2024)
- Recognized in Euromoney’s Competition and Antitrust Expert Guide (2021)
- Selected for inclusion in New York Super Lawyers "Rising Stars" (2015-2017)
- Vice Chair, US Comments and Policy Committee, American Bar Association
- Member, Antitrust Section, American Bar Association
- Antitrust and Trade Regulation Committee, New York City Bar Association (2016-2019)
- District of Columbia
- New York
- U.S. District Court for the Southern District of New York
- U.S. Court of Appeals for the Second Circuit
- U.S. District Court for the District of Columbia
- B.A., magna cum laude, Amherst College
- J.D., with honors, Emory University School of Law,
Executive Managing Editor, Emory Law Journal